Interventional Study of Nonpharmaceutical Measures to Prevent COVID-19 Aboard Cruise Ships.
COVID-19
Europe
FFP2
N95
SARS-CoV-2
antibodies
coronavirus
cruise
facemask
investigation
isolation
mask
nonpharmaceutical measures
outbreak
physical distancing
quarantine
respiratory infections
sanitation
severe acute respiratory syndrome coronavirus 2
ship
surveillance
travel
vaccine
vessel
viruses
zoonoses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
medline:
26
4
2024
pubmed:
26
4
2024
entrez:
26
4
2024
Statut:
ppublish
Résumé
Cruise ships carrying COVID-19-vaccinated populations applied near-identical nonpharmaceutical measures during July-November 2021; passenger masking was not applied on 2 ships. Infection risk for masked passengers was 14.58 times lower than for unmasked passengers and 19.61 times lower than in the community. Unmasked passengers' risk was slightly lower than community risk.
Identifiants
pubmed: 38666667
doi: 10.3201/eid3005.231364
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM